Diagnósticos da América S.A (DASA3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 16 Oct 2026
Key indicators
| Last close | BRL 4.660 |
|---|---|
| 52-week range | 1.280 – 5.290 |
| Return, 1 month / 3 months | +64.7% / +66.4% |
| Return, 1 year / 3 years | +253.0% / −62.4% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 88.6% |
| Worst drawdown (1 year) | -54.1% |
| Average daily value traded | 4.33M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Diagnósticos da América, known as Dasa, is a Brazilian healthcare company that runs clinical laboratories and diagnostic imaging centres. It provides laboratory tests, pathology services and imaging examinations such as scans and ultrasound to patients, hospitals and doctors across Brazil. The company is based in Brazil and serves the country's private and public healthcare markets through a network of diagnostic facilities and hospital-based services.
The shares are listed on the Sao Paulo Exchange in Brazil under the code DASA3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Diagnósticos da América S.A (DASA3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 4.660 on 16 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 330 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 253.0% and over the last three months it rose 66.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 40.4% | ||
| From 52-week high | -10.7% | ||
| Momentum | 96 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 66.4% | ||
| 6-month return | 45.2% | ||
| 12-month return, skipping the last month | 114.4% | ||
| Stability (higher is calmer) | 15 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 88.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -54.1% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 4.33M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −4.7% |
|---|---|
| 1 month | +64.7% |
| 3 months | +66.4% |
| 6 months | +45.2% |
| 1 year | +253.0% |
| 3 years | −62.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 3.213 / 3.320 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.296 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Dec 2022 | BRL 0.0970 |
| 27 Dec 2021 | BRL 0.3013 |
| 12 Jan 2021 | BRL 0.2854 |
| 30 Dec 2019 | BRL 0.5634 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.